Neuropilin‐1 is not a marker of human Foxp3 + Treg
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Treg are immune cells that play a critical role in the regulation of the immune response. Although the transcription factor Foxp3 is widely accepted as the standard marker of Treg, specific surface markers are needed to better characterize these cells and decipher their mechanisms of action. Neuropilin‐1 (Nrp‐1), a membrane protein primarily involved in the nervous system, was identified as a specific marker of murine Treg, but its expression has not been rigorously investigated in human Treg. Here we show that in contrast to murine Treg and regardless of their origins (blood, thymus, spleen, lymph node or tonsil), human Foxp3 + Treg do not specifically express Nrp‐1. However, a population of Foxp3 − Nrp‐1 + T cells can be detected in human secondary lymphoid organs, and Nrp‐1 expression is induced on peripheral blood T lymphocytes upon in vitro activation. We conclude that Nrp‐1 cannot be used as a specific marker of human Treg, but might represent a novel activation marker of human T cells both in vitro and in vivo .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuropilin-1 (Nrp-1) has been proposed to mark stable mouse Tregs, but expression of this protein is almost undetectable in human peripheral Tregs [369].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [369]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Neuropilin Is a Semaphorin III Receptor
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R. J., & Ginty, D. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,180
Frontline: Neuropilin‐1: a surface marker of regulatory T cells
Bruder, D., Probst‐Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., & Hansen, W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324799 · Cited by 453
Sarris, M., Andersen, K. G., Randow, F., Mayr, L., & Betz, A. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.012 · Cited by 359
A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response
Tordjman, R., Lepelletier, Y., Lemarchandel, V., Cambot, M., Gaulard, P., Hermine, O., & Roméo, P.-H. (2002) · Nature Immunology · doi:10.1038/ni789 · Cited by 322
Self-citationSemaphorin–Neuropilin Interactions Underlying Sympathetic Axon Responses to Class III Semaphorins
Chen, H., He, Z., Bagri, A., & Tessier-Lavigne, M. (1998) · Neuron · doi:10.1016/s0896-6273(00)80648-0 · Cited by 291
Glinka, Y., & Prud’homme, G. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208090 · Cited by 267
Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions
Dzionek, A., Inagaki, Y., Okawa, K., Nagafune, J., Röck, J. Ü., Sohma, Y., Winkels, G., Zysk, M., Yamaguchi, Y., & Schmitz, J. Ü. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00752-8 · Cited by 221
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Yadav, M., Louvet, C., Davini, D., Gardner, J. M., Martinez-Llordella, M., Bailey-Bucktrout, S., Anthony, B. A., Sverdrup, F. M., Head, R., Kuster, D. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120822 · Cited by 649
“Nrp-1, T reg cells in secondary lymphoid organs have been shown to express Nrp-1 (Battaglia et al., 2008; Milpied et al., 2009).”
BackgroundInterferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627
Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
Delgoffe, G. M., Woo, S.-R., Turnis, M. E., Gravano, D. M., Guy, C., Overacre, A. E., Bettini, M. L., Vogel, P., Finkelstein, D., Bonnevier, J., et al. (2013) · Nature · doi:10.1038/nature12428 · Cited by 587
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Prud’homme, G. J., & Glinka, Y. (2012) · Oncotarget · doi:10.18632/oncotarget.626 · Cited by 275
Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
Yadav, M., Stephan, S., & Bluestone, J. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00232 · Cited by 273
“This is consistent with earlier reports with exception of one study in which Nrp-1 Tregs were detected in human lymphoid organs (109, 110).”
ResultMultifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy
Roy, S., Bag, A. K., Singh, R. K., Talmadge, J. E., Batra, S. K., & Datta, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01228 · Cited by 240
“Also, NRP1+ T cells identified in the secondary lymphoid organs comprised only a very minor population of the entire T cell pool and mostly associated with non-regulatory phenotype (197).”
BackgroundNeuropilin 1: function and therapeutic potential in cancer
Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1500-0 · Cited by 233
“NRP1 is not differentially expressed on human tTregs compared with murine studies that report NRP1 was expressed on a majority of murine Tregs—up to 70 % of circulating Tregs [64].”
BackgroundMethodInfluentialTREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214
Santegoets, S. J. A. M., Dijkgraaf, E. M., Battaglia, A., Beckhove, P., Britten, C. M., Gallimore, A., Godkin, A., Gouttefangeas, C., de Gruijl, T. D., Koenen, H. J. P. M., et al. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1729-x · Cited by 211
“16 N eu ro pi lin -1 D ir ec tly e x vi vo C el l s ur fa ce E xp re ss ed o n a hi gh ly e ffi ci en t T re g su bs et ( C D 25 po s F ox p3 po s ) in T D L N 1/ 10 [5 2– 54 ]”
BackgroundTregs: Where We Are and What Comes Next?
Zhao, H., Liao, X., & Kang, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01578 · Cited by 196
“Neuropilin-1 Expression of Neuropilin-1 on human Tregs has been a contentious subject (60, 61).”
BackgroundModulation of regulatory T cell function and stability by co-inhibitory receptors
Lucca, L. E., & Dominguez-Villar, M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0296-3 · Cited by 189
Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Mayne, C. G., & Williams, C. B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f5a3 · Cited by 178
“Unfortunately, Nrp-1 does not seem to be expressed by human Treg cells, so the utility of this marker for clinical studies may be limited.(65) Differences in the methylation status of the Foxp3 genetic”
BackgroundPhenotypical characterization of regulatory T cells in humans and rodents
Rodríguez-Perea, A. L., Arcia, E. D., Rueda, C. M., & Velilla, P. A. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12804 · Cited by 166
Szurek, E., Cebula, A., Wojciech, L., Pietrzak, M., Rempala, G., Kisielow, P., & Ignatowicz, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141161 · Cited by 163
“A similar conclusion has also been reached when expression of Nrp-1 and Helios by Tregs was analyzed in different inbred or outbred strains of mice or in humans [54] [55].”
BackgroundRegulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
Leclerc, M., Voilin, E., Gros, G., Corgnac, S., de Montpréville, V., Validire, P., Bismuth, G., & Mami-Chouaib, F. (2019) · Nature Communications · doi:10.1038/s41467-019-11280-z · Cited by 154
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
Chuckran, C. A., Liu, C., Bruno, T. C., Workman, C. J., & Vignali, D. A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000967 · Cited by 147
Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.
Lin, X.-H., Chen, M., Liu, Y., Guo, Z., He, X., Brand, D. D., & Zheng, S. G. (2013) · PubMed · Cited by 198
Treg therapy in transplantation: a general overview
Romano, M., Tung, S. L., Smyth, L. A., & Lombardi, G. (2017) · Transplant International · doi:10.1111/tri.12909 · Cited by 132
“(pTregs) [33,34] in human, this is not possible [35].”
BackgroundRegulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential
Spitz, C., Winkels, H., Bürger, C., Weber, C., Lutgens, E., Hansson, G. K., & Gerdes, N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2080-2 · Cited by 137
“Recently, the membrane protein neuropilin-1 (Nrp1) was identified as a specific marker of murine but not human nTregs [79, 93].”
BackgroundIntratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
Yano, H., Andrews, L. P., Workman, C. J., & Vignali, D. A. A. (2019) · Immunology · doi:10.1111/imm.13067 · Cited by 116
Tumor-Targeted Nanomedicine for Immunotherapy
Cabral, H., Kinoh, H., & Kataoka, K. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00518 · Cited by 123
Regulatory T Cells in Allergy and Asthma
Martín‐Orozco, E., Norte‐Muñoz, M., & Martínez-García, J. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00117 · Cited by 122
“These results were confirmed by using an anti-Nrp-1 antibody to abrogate Treg-mediated suppressive activity (159, 160).”
BackgroundThe Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells
Brummelman, J., Pilipow, K., & Lugli, E. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.007 · Cited by 130
Singh, K., Hjort, M., Thorvaldson, L., & Sandler, S. (2015) · Scientific Reports · doi:10.1038/srep07767 · Cited by 108
Neuropilins: A New Target for Cancer Therapy
Grandclément, C., & Borg, C. (2011) · Cancers · doi:10.3390/cancers3021899 · Cited by 93
The Dual Role of Treg in Cancer
Frydrychowicz, M., Boruczkowski, M., Kolecka-Bednarczyk, A., & Dworacki, G. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12615 · Cited by 96
Induced regulatory T cells in inhibitory microenvironments created by cancer
Whiteside, T. L. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927432 · Cited by 90
“CD45RA + + or -iTregs are CD45RO [25,55] CTLA-4 + + + Upregulated on Tregs [25] CD127 + Used for negative selection of Tregs [18] HELIOSzz + -z ± Transient expression in activated T cells [27-29] ICOS** + + iTregs in melanoma TIL upregulate expression [30] NRP1** ± + ± Restricted expression [33,34] CD39** + + Ectonucl…”
BackgroundHarnessing Regulatory T cells to Suppress Asthma
Thorburn, A. N., & Hansbro, P. M. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0342tr · Cited by 98
“However, Nrp-1 cannot be used as a marker of human Foxp31 Tregs, because Nrp-1 is not only expressed on human Foxp31 Tregs, and occurs on other CD41 cells (50).”
BackgroundHuman FOXP 3+ T regulatory cell heterogeneity
Mohr, A., Malhotra, R., Mayer, G., Gorochov, G., & Miyara, M. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1005 · Cited by 99
“Neuropilin-1 has also been described as a surface marker enabling the discrimination between murine tTregs and pTregs(18,19) but such finding could not be observed in humans.(20,21) It is therefore still uncertain how to dissect tTregs from pTreg cells in humans.”
ResultAlbonici, L., Giganti, M. G., Modesti, A., Manzari, V., & Bei, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122970 · Cited by 94
“Since NRP1 expression can be induced on peripheral blood T cells upon activation, NRP1 might represent at most a novel activation marker for human T cells [136].”
BackgroundHome Sweet Home: The Tumor Microenvironment as a Haven for Regulatory T Cells
Ondondo, B., Jones, E., Godkin, A. J., & Gallimore, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00197 · Cited by 98
“The validity of both helios and Nrp1 as true discriminators of tTregs versus pTregs has however been disputed, thus no definitive conclusions can be drawn from the studies described above (82, 83).”
BackgroundRegulatory T cells in solid organ transplantation
Atif, M., Conti, F., Gorochov, G., Oo, Y. H., & Miyara, M. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1099 · Cited by 86
“However, Helios/Nrp-1 on their own cannot categorise tTregs and pTreg cells in humans.(23,24) A further way of identifying Treg cells is by classifying all CD4 T cells on the basis of CD45RA”
BackgroundTreg cell therapy: How cell heterogeneity can make the difference
Giganti, G., Atif, M., Mohseni, Y., Mastronicola, D., Grageda, N., Povoleri, G. A., Miyara, M., & Scottà, C. (2021) · European Journal of Immunology · doi:10.1002/eji.201948131 · Cited by 82
Harnessing the biology of regulatory T cells to treat disease
Wardell, C. M., Boardman, D. A., & Levings, M. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01089-x · Cited by 100
“In mice, surface expression of neuro-pilin 1 (NRP1) is often used to define tT reg cells as it is not expressed by pT reg cells 26 but, in humans, this receptor does not effectively identify T reg cellular origin 27 .”
Jones, K. S., Lambert, S., Bouttier, M., Bénit, L., Ruscetti, F. W., Hermine, O., & Pique, C. (2011) · Viruses · doi:10.3390/v3060794 · Cited by 81
“Both primary CD4 + and CD8 + T cells up-regulate NRP-1 upon activation [60], consistent with previous reports that HTLV-1 and HTLV-2 bind to activated, but not naïve, T cells [61,62].”
Self-citationPeripheral and Thymic Foxp3+ Regulatory T Cells in Search of Origin, Distinction, and Function
Dhamne, C. A., Chung, Y., Alousi, A. M., Cooper, L. J. N., & Tran, D. Q. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00253 · Cited by 90
“Another study also argues against the applicability of CD304 as a marker of human Tregs (51).”
Regulatory T cells Versus Th17: Differentiation of Th17 Versus Treg, Are They Mutually Exclusive?
Zheng, S. G. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_6 · Cited by 78
“[23] Milpied P, Renand A, Bruneau J, Mendes-da-”
BackgroundHuman Semaphorin-4A drives Th2 responses by binding to receptor ILT-4
Lü, N., Li, Y., Zhang, Z., Xing, J., Sun, Y., Yao, S., & Chen, L. (2018) · Nature Communications · doi:10.1038/s41467-018-03128-9 · Cited by 77
Regulatory T-Cell Therapy in the Induction of Transplant Tolerance: The Issue of Subpopulations
Edozie, F. C., Nova‐Lamperti, E., Povoleri, G. A. M., Scottà, C., John, S., Lombardi, G., & Afzali, B. (2014) · Transplantation · doi:10.1097/tp.0000000000000243 · Cited by 82
“SCID, severe combined immunodeficiency; ICOS, inducible T-cell costimulator; Nrp-1, Neuropilin 1; TNFR2, tumor necrosis factor receptor 2; GARP, glycoprotein A repetitions predominant; LAP, latency-associated peptide; VEGF, vascular endothelial growth factor; Tregs, regulatory T cells; IL, interleukin; ATP, adenosine…”
BackgroundInfluentialRegulatory T Cells in Pregnancy: It Is Not All About FoxP3
Krop, J., Heidt, S., Claas, F. H. J., & Eikmans, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01182 · Cited by 86
“In humans, Helios is found on Tregs, but Nrp1 is not found on peripheral blood Tregs and can, therefore, be excluded as tTreg marker (66, 73).”
BackgroundInterplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals
Sehrawat, S., & Rouse, B. T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00341 · Cited by 80
Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
Iragavarapu‐Charyulu, V., Wojcikiewicz, E. P., & Urdaneta, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00346 · Cited by 80
Milpied, P., Massot, B., Renand, A., Diem, S., Herbelin, A., Leite-de-Moraes, M., Rubio, M.-T., & Hermine, O. (2011) · Blood · doi:10.1182/blood-2011-01-329268 · Cited by 70
Self-citationRestoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells
Kumar, P., Saini, S., Khan, S. M., Lele, S. S., & Prabhakar, B. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.09.008 · Cited by 77
Functional heterogeneity of gut‐resident regulatory T cells
Luu, M., Steinhoff, U., & Visekruna, A. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.39 · Cited by 70
TGF-β in transplantation tolerance
Regateiro, F. S., Howie, D., Cobbold, S. P., & Waldmann, H. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.003 · Cited by 69
“In contrast to murine Treg, Nrp1 is not expressed on human naı̈ve Foxp3 cells but is upregulated upon activation in all T cells [79].”
BackgroundDisrupted regulatory T cell homeostasis in inflammatory bowel diseases
Pedros, C., Duguet, F., Saoudi, A., & Chabod, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.974 · Cited by 69
T memory stem cells are the hierarchical apex of adult T-cell leukemia
Nagai, Y., Kawahara, M., Hishizawa, M., Shimazu, Y., Sugino, N., Fujii, S., Kadowaki, N., & Takaori‐Kondo, A. (2015) · Blood · doi:10.1182/blood-2014-10-607465 · Cited by 71
The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
Bayati, F., Mohammadi, M., Valadi, M., Jamshidi, S., Foma, A. M., & Sharif‐Paghaleh, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585819 · Cited by 67
“Although, unlike mice Tregs, Nrp-1 expression on both human conventional T cells and Tregs is consistently low and cannot be regarded as a human Treg marker (90).”
BackgroundCD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection
Simonetta, F., & Bourgeois, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00215 · Cited by 61
“Importantly, NRP1 expression remains stable on NRP1 positive or negative Treg subsets upon TCR mediated or lymphopenia induced cell activation and proliferation while environmental inflammatory stimuli have been shown to modulate NRP1 expression (101).”
BackgroundInfluentialGPA33: A Marker to Identify Stable Human Regulatory T Cells
Opstelten, R., de Kivit, S., Slot, M. C., van den Biggelaar, M., Iwaszkiewicz‐Grześ, D., Gliwiński, M., Scott, A. M., Blom, B., Trzonkowski, P., Borst, J. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901250 · Cited by 57
“in mice, but is not present on human Treg cells in blood (49, 54, 55).”
BackgroundDefining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function
Gootjes, C., Zwaginga, J. J., Roep, B. O., & Nikolić, T. (2024) · Cells · doi:10.3390/cells13110941 · Cited by 53
Roux, C., Saviane, G., Pini, J., Belaïd, N., Dhib, G., Voha, C., Ibáñez, L., Boutin, A., Mazure, N. M., Wakkach, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01991 · Cited by 49
Gene therapy with regulatory T cells: A beneficial alliance
Biswas, M., Kumar, S. R. P., Terhorst, C., & Herzog, R. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00554 · Cited by 41
“Other natural Treg markers such as neuropilin are specific for mice (45, 46).”
BackgroundRegulatory Cells and Transplantation Tolerance
Cobbold, S. P., & Waldmann, H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015545 · Cited by 42
Chuckran, C. A., Cillo, A. R., Moskovitz, J. M., Overacre-Delgoffe, A. E., Somasundaram, A., Shan, F., Magnon, G. C., Kunning, S. R., Abécassis, I., Zureikat, A. H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8495 · Cited by 41
Microbial modulation of intestinal T helper cell responses and implications for disease and therapy
Geuking, M. B., & Burkhard, R. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00335-w · Cited by 39
Chaudhary, B., & Elkord, E. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.977784 · Cited by 35
“lymph nodes and tonsils, including TDLN of cervical cancer patients where NRP1 expression was significantly upregulated in metastatic TDLN (mTDLN) compared to metastasis-free TDLN [10-12,35,37].”
BackgroundInfluentialJiang, Z., Zhu, H., Wang, P., Que, W., Zhong, L., Li, X., & Du, F. (2022) · MedComm · doi:10.1002/mco2.137 · Cited by 38
Edelbauer, M., Datta, D., Vos, I. H. C., Basu, A., Stack, M. P., Reinders, M. E. J., Sho, M., Calzadilla, K., Ganz, P., & Briscoe, D. M. (2010) · Blood · doi:10.1182/blood-2009-11-252460 · Cited by 33
Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity
Nirmala, S. S., Kayani, K., Gliwiński, M., Hu, Y., Iwaszkiewicz‐Grześ, D., Piotrowska, M., Sakowska, J., Tomaszewicz, M., Morales, J. M. M., Lakshmi, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321228 · Cited by 45
Treg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla, R., Acevedo, D., Luo, Y., Esteve‐Solé, A., Vlagea, A. D., Correa‐Rocha, R., Seoane-Reula, E., & Alsina, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278759 · Cited by 39
Dendritic Cells in the Periphery Control Antigen-Specific Natural and Induced Regulatory T Cells
Yamazaki, S., & Morita, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00151 · Cited by 34
“The two types of T-regs appear indistinguishable on the surface, but the expression of Neuropilin can distinguish Natural T-regs and Induced T-regs in mice but not in humans (Milpied et al., 2009; Weiss et al., 2012; Yadav et al., 2012).”
BackgroundIkaros Is a Negative Regulator of B1 Cell Development and Function
Macias-Garcia, A., Heizmann, B., Sellars, M., Marchal, P., Dali, H., Pasquali, J., Muller, S., Kastner, P., & Chan, S. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.704239 · Cited by 34
“3 ) is highly related to the B cell co-signaling molecule CD20 (47); Nrp2 (up 2 ), homologous to Nrp1, which is induced in activated T cells (48).”
BackgroundSemaphorin 3A in the Immune System: Twenty Years of Study
Kiseleva, E. P., & Rutto, K. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922070069 · Cited by 28
“Such receptors appear upon cell activation, and allow them to respond to semaphorin 3A stimuli [25, 38, 40].”
BackgroundMethodInfluentialXu, J., Li, X., Yuan, Q., Wang, C., Xu, L., Wei, X., Liu, H., Yu, B., An, Z., Zhao, Y., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.08.023 · Cited by 26
FoxP3 mRNA splice forms in synovial CD4+ T cells in rheumatoid arthritis and psoriatic arthritis
Ryder, L. R., Bartels, E. M., Woetmann, A., MADSEN, H. O., Ødum, N., Bliddal, H., Danneskiold‐Samsøe, B., Ribel-Madsen, S. M., & Ryder, L. P. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02848.x · Cited by 27
Regulatory T Cells and Transplantation Tolerance
Hilbrands, R., Howie, D., Cobbold, S. P., & Waldmann, H. (2013) · Immunotherapy · doi:10.2217/imt.13.69 · Cited by 26
Regulatory T cells in inflammation and resolution of acute lung injury
Wang, L., Jiang, W., Wang, X., Tong, L., & Song, Y. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13527 · Cited by 25
The ‘Treg paradox’ in inflammatory arthritis
Schnell, J. T., Briviesca, R. L., Kim, T., Charbonnier, L., Henderson, L. A., van Wijk, F., & Nigrovic, P. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01190-w · Cited by 32
Convergences and Divergences of Thymus- and Peripherally Derived Regulatory T Cells in Cancer
Burocchi, A., Colombo, M. P., & Piconese, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00247 · Cited by 27
“Unfortunately, human Treg do not express Nrp-1 (63), thus this marker cannot be used to estimate the relative contribution of tTreg or pTreg in human cancers.”
BackgroundSznurkowska, K., Luty, J., Bryl, E., Witkowski, J. M., Hermann, B., Landowski, P., Kosek, M., & Szlagatys‐Sidorkiewicz, A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s268484 · Cited by 25
Neuropilin-1 in Transplantation Tolerance
Campos-Mora, M., Morales, R. A., Gajardo, T., Catalán, D., & Pino-Lagos, K. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00405 · Cited by 23
“Furthermore, Foxp3 expression in human Tregs is not characteristic of these suppressor cells compared to murine Tregs (82).”
BackgroundFigliuolo, V. R., Jamwal, D. R., & Kiela, P. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_9 · Cited by 28
Developing T‐cell migration: role of semaphorins and ephrins
Mendes‐da‐Cruz, D. A., Stimamiglio, M. A., Múñoz, J. J., Alfaro, D., Terra‐Granado, E., García‐Ceca, J., Alonso‐Colmenar, L. M., Savino, W., & Zapata, A. G. (2012) · The FASEB Journal · doi:10.1096/fj.11-202952 · Cited by 24
“their mechanisms of action may be different (38).”
BackgroundSelf-citationRenand, A., Milpied, P., Rossignol, J., Bruneau, J., Lemonnier, F., Dussiot, M., Coulon, S., & Hermine, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085589 · Cited by 25
“In previous studies in mice and humans, the expression of Nrp1 in T cells has been associated with either proliferation or suppressive activity [18-25].”
BackgroundInfluentialSelf-citationBachy, E., Bernaud, J., Roy, P., Rigal, D., & Nicolini, F. E. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08453.x · Cited by 23
Neuropilin-1 Acts as a Receptor for Complement Split Products
Battin, C., Linhares, A. D. S., Paster, W., Isenman, D. E., Wahrmann, M., Leitner, J. M., Zlabinger, G. J., Steinberger, P., & Hofer, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02209 · Cited by 23
“Recently, semaphorin 4a (Sema4A) was described as a novel NRP1 ligand critically involved in suppression of anti-tumor responses by mTregs, but additional ligands mediating immunemodulatory effects of NRP1 are not well-defined (39).”
BackgroundInfluentialMorgana, F., Opstelten, R., Slot, M. C., Scott, A. M., van Lier, R. A. W., Blom, B., Mahfouz, A. E., & Amsen, D. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100506 · Cited by 30
Navigating T-Cell Immunometabolism in Transplantation
Tanimine, N., Turka, L. A., & Priyadharshini, B. (2017) · Transplantation · doi:10.1097/tp.0000000000001951 · Cited by 23
Meyerson, H., Blidaru, G., Edinger, A., Osei, E., Schweitzer, K., Fu, P., & Ho, L. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp6vdbl4brxrqa · Cited by 24
Regulatory T cells in ischemic cardiovascular injury and repair
Zhuang, R., & Feinberg, M. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.004 · Cited by 21
Tran-Van, H., Avota, E., Börtlein, C., Mueller, N., & Schneider-Schaulies, S. (2011) · European Journal of Immunology · doi:10.1002/eji.201040847 · Cited by 21
Semaphorins as Potential Immune Therapeutic Targets for Cancer
Jiang, J., Zhang, F., Wan, Y., Fang, K., Yan, Z., Ren, X., & Zhang, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.793805 · Cited by 27
Chen, W., Huang, W., Xue, Y., Chen, Y., Qian, W., Ma, J., August, A., Wang, J., Zheng, S. G., & Lin, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900139 · Cited by 25
“It was also noticed that Nrp-1 is not a marker of human nature FOXP3Treg, but can be induced in human blood T cells upon in vitro TCR activation (10).”
BackgroundGeem, D., Ngo, V. L., Harusato, A., Chassaing, B., Gewirtz, A. T., Newberry, R. D., & Denning, T. L. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.12.009 · Cited by 19
Chaoul, N., Tang, A., Desrues, B., Oberkampf, M., Fayolle, C., Ladant, D., Sainz‐Perez, A., & Leclerc, C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1404213 · Cited by 21
“S3D-F), showing that Nrp1 expression on Teffs is a marker of their activation as previously suggested.(30)”
BackgroundYoung, J. S., Yin, D., Vannier, A., Alegre, M., & Chong, A. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01385 · Cited by 18
A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives
Han, Z., Ma, K., Tao, H., Liu, H., Zhang, J., Sai, X., Li, Y., Chi, M., Nian, Q., Song, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.826732 · Cited by 21
Regulatory T Cell-Mediated Tissue Repair
Hong, J., & Kim, B.-S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-0445-3_14 · Cited by 16
Regulatory T Cells: Central Concepts from Ontogeny to Therapy
Khor, B. (2017) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2016.07.003 · Cited by 15
“marker neuropilin-1 helps distinguish tTregs from pTregs in mice but appears less Treg-specific in humans [17-19].”
BackgroundTherapeutic application of T regulatory cells in composite tissue allotransplantation
Yang, J.-H., & Eun, S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1322-5 · Cited by 16
“These results are challenged by the observation that there are no differences in expression levels of Helios and Nrp-1 between tTregs and pTreg cells in both mice and human systems [67, 68].”
ResultEnhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus
Hoseini-Aghdam, M., Sheikh, V., Eftekharian, M. M., Rezaeepoor, M., & Behzad, M. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.06.003 · Cited by 13
Grebinoski, S., Pieklo, G. P., Zhang, Q., Visperas, A., Cui, J., Goulet, J., Xiao, H., Brunazzi, E. A., Cardello, C., Herrada, A. A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300216 · Cited by 14
Context- and Tissue-Specific Regulation of Immunity and Tolerance by Regulatory T Cells
Ulges, A., Schmitt, E., Becker, C., & Bopp, T. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.08.002 · Cited by 13
Yuan, Q., Hong, S., Shi, B., Kers, J., Li, Z., Pei, X., Xu, L., Wei, X., & Cai, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061151 · Cited by 12
“do not specifically express Nrp1 and Nrp1 expression is induced on peripheral blood T lymphocytes upon in vitro activation as well [26].”
BackgroundStabilizing Human Regulatory T Cells for Tolerance Inducing Immunotherapy
He, X., Koenen, H. J. P. M., Slaats, J., & Joosten, I. (2017) · Immunotherapy · doi:10.2217/imt-2017-0017 · Cited by 13
Agostino, N. M., Saraceni, C., Kincaid, H. M., Shi, W., Nevala, W. K., Markovic, S. N., & Nair, S. (2015) · SpringerPlus · doi:10.1186/s40064-015-0951-5 · Cited by 9
“Although neuropilin1 has been identified as a specific marker of murine Treg its applicability as a marker of human Treg has been questioned (Milpied et al. 2009).”
Background
Metadata
- Authors
- Milpied, P., Renand, A., Bruneau, J., Mendes‐Da‐Cruz, D. A., Jacquelin, S., Asnafi, V., Rubio, M., MacIntyre, E., Lepelletier, Y., & Hermine, O.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Corresponding author
- Hermine, Olivier
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2009-06
- Volume
- 39
- Issue
- 6
- Pages
- 1466-1471
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1968346082
- Cited by
- 136
- References
- 18
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 7 · 2021: 7 · 2020: 12 · 2019: 6 · 2018: 14 · 2017: 14 · 2016: 12 · 2015: 6 · 2014: 5 · 2013: 17 · 2012: 5
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Arca - Repositório Institucional da Fiocruz (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- neuropilin-1, Foxp3, regulatory T cells, Treg markers, T cell activation, secondary lymphoid organs, peripheral blood T cells
- MeSH terms
- Animals, Antigens, Surface, Cell Count, Dendritic Cells, Female, Humans, Leukocytes, Mononuclear, Lymphocyte Activation, Lymphoid Tissue, Mice, Inbred C57BL, T-Lymphocytes, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Neuropilin-1, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.